Trimedx Deploys AI Agents to Cut Medical Device Cyber-Fix Time by 75%

INDIANAPOLIS, IN – August 26, 2026 – In a move that directly confronts a mounting crisis in healthcare, clinical asset intelligence firm Trimedx has announced the deployment of agentic AI within its TMX Protect platform. The company claims these new capabilities can reduce the time health systems spend remediating medical device cybersecurity threats by a staggering 75%, a figure that could fundamentally alter the economics and efficacy of hospital security operations.

The announcement arrives at a critical juncture. According to industry data, over half of all connected medical devices in use today harbor known critical vulnerabilities, and a startling 99% of hospitals manage devices with known, actively exploited security flaws. This digital fragility transforms life-saving equipment—from infusion pumps to MRI machines—into potential entry points for cyberattacks, threatening patient data, operational stability, and even patient safety itself. Overwhelmed by the sheer volume of alerts, healthcare cybersecurity teams have been fighting a losing battle of prioritization and patching. Trimedx is betting that its new AI-driven approach can finally turn the tide.

From Reactive Patching to Proactive Protection

For years, the standard approach to medical device security has been a reactive cycle of identifying vulnerabilities and deploying patches—a process often too slow and cumbersome to keep pace with evolving threats. The core innovation in the TMX Protect platform is its attempt to break this cycle, shifting the paradigm from reactive cleanup to proactive, intelligent risk management.

The system moves beyond simply flagging a vulnerability. It contextualizes the threat by cross-referencing it with Trimedx's vast proprietary database, built on a service history of over 7.4 million devices. The platform's AI assesses risk based not only on cybersecurity metrics—like whether a flaw is being actively exploited by ransomware groups—but also on clinical considerations. It helps answer the crucial question: which vulnerable device, if compromised, poses the greatest immediate threat to patient care? This dual-focus prioritization allows resource-strapped IT departments to concentrate their efforts where the impact is most significant.

"Health systems are managing an increasingly complex landscape of connected medical devices and cybersecurity threats," said Trimedx Chief Data and AI Officer Srilekha Akula. "With more than 50% of connected medical devices having a known critical vulnerability, teams need better ways to identify and prioritize risk." By enabling teams to focus on what matters most, the platform aims to prevent disruptions before they can cascade through a hospital's critical infrastructure.

This proactive stance also extends to devices that lack a manufacturer-approved patch, a common and vexing problem with older medical equipment. The platform assists in identifying and tracking alternative mitigation strategies, such as network segmentation, creating a comprehensive, closed-loop remediation workflow from detection to resolution.

The 'Agentic AI' Advantage: Speaking Security into Existence

Central to this new capability is the concept of "agentic AI." Unlike traditional machine learning models that excel at pattern recognition, an agentic system is designed to understand user intent, perform multi-step tasks, and interact in a more conversational, goal-oriented manner. Trimedx has integrated this functionality through a natural-language interface.

This means a hospital's cybersecurity analyst can now ask the platform direct questions in plain English, such as, "Show me all infusion pumps with known exploited vulnerabilities that are currently in use in the ICU," or "Generate a risk assessment report for all our diagnostic imaging devices running on outdated Windows operating systems." The AI agent then queries the underlying data, synthesizes the information, and presents an actionable answer, report, or prioritized list.

This accessibility is a key differentiator. It democratizes access to complex cybersecurity intelligence, empowering a broader range of clinical engineering and IT staff to make informed decisions without needing to be elite data scientists. "The new agentic AI capabilities within TMX Protect help turn large volumes of device and vulnerability data into actionable insights, enabling teams to prioritize what matters most and take steps that strengthen security while supporting patient care," Akula explained.

This technology represents a significant leap from static dashboards and endless spreadsheets. By creating an interactive, intelligent partner for security teams, Trimedx aims to dramatically accelerate the decision-making process that precedes any remediation action, which is the foundation of its 75% time-reduction claim.

Navigating a Crowded and Regulated Market

Trimedx is not alone in its quest to secure the Internet of Medical Things (IoMT). The market is a dynamic and competitive space, with established players like Claroty (which acquired Medigate) and Cynerio offering robust platforms for device discovery, risk analysis, and network segmentation. These firms also leverage AI to provide deep visibility and threat detection, setting a high bar for market entry.

Where Trimedx seeks to differentiate itself is by combining its agentic AI interface with its unique position as a clinical asset performance company. Its platform is not just built on network traffic analysis but is informed by decades of hands-on service data from technicians on the clinical floor, providing a level of device-specific intelligence that competitors may lack. The company boasts up to 95% identification and matching accuracy for connected medical devices, a critical foundation for any effective security strategy.

This push for innovation is further fueled by mounting regulatory pressure. The U.S. Food and Drug Administration (FDA) has significantly tightened its cybersecurity requirements for medical device manufacturers, mandating a "secure by design" approach and post-market surveillance. Simultaneously, potential updates to the HIPAA Security Rule are expected to mandate stricter controls for protecting patient health information. For hospitals, solutions like TMX Protect are becoming less of a strategic advantage and more of a compliance necessity, providing the auditable records and risk management frameworks required to satisfy regulators.

The Real-World Gauntlet: Implementation and Adoption

Despite the promise of AI-driven efficiency, the path to adoption is not without its challenges. Health systems are complex ecosystems, and integrating any new platform requires careful planning to navigate legacy systems, ensure data quality, and foster alignment between IT, cybersecurity, and clinical engineering departments. The effectiveness of any AI is contingent on the quality of the data it is fed, and establishing an accurate, comprehensive inventory of all connected devices is a critical, and often difficult, first step.

However, the risks of inaction are far greater. As cyberattacks on healthcare facilities become more frequent and sophisticated, the financial, reputational, and clinical consequences of a breach are severe. By offering a tool that not only identifies threats but also dramatically accelerates the response, Trimedx is providing a compelling solution to one of the most urgent problems facing modern healthcare.